Company / Tangible Book Value per Share
Wave Life Sciences Ltd. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$3.39
FY2025
5-year range
$0.46 / $3.39
FY2021-FY2025
Trend
+92.6%
vs FY2024
Sector context
#119 of 209
Health Care
What the data says
At $3.39, Wave Life Sciences Ltd.'s tangible book value per share ranks #119 of 209 in the Health Care sector. Improved from $0.46 to $3.39 over the past 2 years.
Based on SEC 10-K filings.
3.39 in FY2025 with a 5-year CAGR of +12.8%.
Improved from $0.46 to $3.39 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +84.1%
- 5-Year CAGR
- +12.8%
- 10-Year CAGR
- -
Sector benchmark
#119 of 209 in Health CareTop 57% of 209This company $3.39 Sector average $93.47
▼
-96.4% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 92.6% year-over-year.
- Ranks #119 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2016.
- Lowest tangible book value per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.39 | +92.6% |
| FY2024 | $1.76 | +285.7% |
| FY2023 | $0.46 | -16.0% |
| FY2022 | $0.54 | -68.0% |
| FY2021 | $1.70 | -8.6% |
| FY2020 | $1.86 | -25.4% |
| FY2019 | $2.49 | -5.6% |
| FY2018 | $2.64 | -55.6% |
| FY2017 | $5.94 | -4.9% |
| FY2016 | $6.25 | +443.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026